James Kastenmayer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Kastenmayer
James Kastenmayer is recorded as CEO at Spyre Therapeutics, Inc. (SYRE). Spyre Therapeutics, Inc. reported in an 8-K filed August 25, 2022 that James Kastenmayer was appointed Interim Chief Executive Officer, effective September 1, 2022.
“Effective as of the Transition Date, the Board appointed James Kastenmayer, the Company’s General Counsel and Corporate Secretary, to succeed Dr. Quinn as Interim Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Spyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cameron Turtle CEO, COO, Board Member
- Cameron Turtle, DPhil CEO, Board Member
- Jeffrey M. Goldberg CEO
- Scott Burrows CFO, Chief Accounting Officer
- Heidy Abreu King-Jones General Counsel
- Jonathan Alspaugh Chief Accounting Officer
- Steven Weber Chief Accounting Officer
- Jeffrey Albers Board Member
- Laurie Stelzer Board Member
- Mark McKenna Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.